Myriad Logo
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk™ gene table
      • Provider resources
        • Order a test
        • Documents & forms
        • Scope of service & lab certificates
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk™ (cancer treatment)
        • MyRisk™ (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers
    • Partnerships
      • Companion diagnostics
ORDER
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Prenatal careIs my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • What are the costs of genetic testing?
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is a pregnancy’s risk of genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Research & whitepapers
        • MyRisk™ gene table
      • Provider resources
        • Order a test
        • Documents & forms
        • Scope of service & lab certificates
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk™ (cancer treatment)
        • MyRisk™ (cancer risk)
        • Prequel®
        • Precise™ Tumor
        • Prolaris®
  • About Myriad
    • Who we are
      • Our science & innovation
      • Corporate & social responsibility
    • Latest news
      • Myriad Genetics Blog
    • Corporate information
      • Our leadership
      • Patient advocacy partners
      • Investor relations
      • Careers
    • Partnerships
      • Companion diagnostics

Category: Breast Cancer

Breast Cancer
  • Category
    • All
    • About Myriad Genetics
    • Breast Cancer
    • Carrier screening
    • Colorectal Cancer
    • Corporate
    • Diversity
    • Employee Spotlight
    • EndoPredict
    • Equity
    • GeneSight
    • Genetic Counselors
    • Hereditary Cancer
    • Inclusion
    • Infographic for Multimedia page
    • Infographics
    • Lynch Syndrome
    • Melanoma
    • Myriad Employees
    • Myriad Science and Facilities
    • Neuroscience
    • Ovarian Cancer
    • Pancreatic Cancer
    • Patient Story
    • Prenatal Screening (NIPS)
    • Prolaris
    • Prostate Cancer
    • Uncategorized
    • Women's Health

Clinically Actionable Studies Presented at Leading Breast Cancer Conference

December 13, 2022

One of the most well-known meetings of breast cancer care experts is the annual San Antonio Breast Cancer Symposium, which takes place every December. It’s a...

Continue Reading

SABCS 2021: Genome-based Data for Breast Cancer Risk and Treatment

December 3, 2021

In the breast cancer research and clinical communities, one of the biggest events of the year is the San Antonio Breast Cancer Symposium. It’s a place where l...

Continue Reading

Why Genetic Testing Should Be Part of Your Mammogram

November 26, 2021

Think back to the last time you went in for a mammogram: did anyone ask whether you’d ever taken a genetic test to learn more about your risk of developing br...

Continue Reading

My Myriad: Sam Barkat, Engineering

October 27, 2021

As we continue our get-to-know-you tour through the Myriad Genetics family, today we sit down with Sam Barkat, Process Sustaining Engineer. She joined the compa...

Continue Reading

Breast Cancer Risk Testing for Women of All Ancestries

October 23, 2021

October is Breast Cancer Awareness Month, and we are excited about the recent launch of a new approach to risk assessment for hereditary breast cancer. It’s n...

Continue Reading

We’re Raising Awareness: Do You Know Your Breast Cancer Risk Profile?

October 1, 2021

It’s October, and you know what that means: falling leaves, Halloween, and — of most importance — Breast Cancer Awareness Month! While there’s much bro...

Continue Reading

ASCO 2021: Clinical Validation of Breast Cancer Risk Testing for People of All Ancestries

July 13, 2021

The Myriad Genetics team, together with leading healthcare collaborators, has been hard at work to expand access to reliable genetic testing results. The result...

Continue Reading

ASCO 2021 Preview: Making Breast Cancer Risk Assessment More Inclusive

May 20, 2021

We are already looking forward to one of the biggest cancer-focused conferences of the year: the annual meeting of the American Society of Clinical Oncology. Th...

Continue Reading

New Publication Demonstrates Value of Combining Clinical and Genetic Risk Models for More Accurate Breast Cancer Risk Prediction

January 29, 2021

A new, peer-reviewed paper published in JCO Precision Oncology shows the clear value of incorporating genetic data with existing clinical models to better predi...

Continue Reading

Celebrating Breast Cancer Awareness Month

October 20, 2020

October is here and it is breast cancer awareness month. I celebrate this month like some people celebrate Halloween or Christmas. Every year, I look forward to...

Continue Reading

3 Tips to Help You Prevent Breast Cancer

October 1, 2019 Continue Reading

Myriad’s Commitment to Fight Cancer

May 29, 2019

Transforming Patients’ Lives with Pioneering Genetic Tests At Myriad, we are proud of our long-standing commitment to fighting cancer, which continues to exac...

Continue Reading

EndoPredict is the Only Test to Answer Three Critical Questions

December 7, 2018

EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine...

Continue Reading

Genetic Testing Helps Personalize Breast Cancer Treatment Decisions

October 1, 2018

According to the American Cancer Society, 1 in 8 U.S. women will be diagnosed with breast cancer in their lifetime.  In 2018, about 266,000 new cases of breast...

Continue Reading

BRACAnalysis CDx Approved by FDA for Patients with HER2- Metastatic Breast Cancer

January 23, 2018

The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic breas...

Continue Reading
  • 1
  • 2
  • 3
  • 4
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Press releases
    • Myriad Genetics’ Blog
  • About
    • Careers
    • Contact us
  • Terms of Use
  • Myriad Genetics, Inc. Privacy Policy
  • Notice of Privacy Practices
  • Language Assistance
  • Cookie Preferences
facebook linkedin twitter instagram youtube

Health. Illuminated.

  • © 2023 Myriad Genetics, Inc.